| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5928845 | American Heart Journal | 2013 | 7 Pages |
Abstract
Despite a higher peri-PCI bleeding risk in women, bivalirudin is as effective as and safer than abciximab plus heparin in women and men with NSTEMI undergoing PCI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Julinda MD, FESC, Franz-Josef MD, FESC, Gjin MD, Lamin MD, Stefanie MD, Fatima Maimer Rodrigues da Cunha, David MD, Robert A. MB, FESC, Jörg MD, FESC, Ilka MD, Steffen MD, Adnan MD, FESC, Jürgen MD,